Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
biological agent |
| gptkbp:approvedBy |
1996 (US)
|
| gptkbp:ATCCode |
B01AD07
|
| gptkbp:brand |
Retavase
|
| gptkbp:CASNumber |
173146-27-5
|
| gptkbp:contraindication |
active internal bleeding
recent surgery history of stroke |
| gptkbp:developedBy |
gptkb:Boehringer_Ingelheim
|
| gptkbp:drugClass |
gptkb:tissue_plasminogen_activator
|
| https://www.w3.org/2000/01/rdf-schema#label |
reteplase
|
| gptkbp:indication |
thrombolysis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
gptkb:plasminogen_activator
fibrinolytic |
| gptkbp:molecularWeight |
39 kDa
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:product |
recombinant tissue plasminogen activator
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
bleeding
allergic reaction |
| gptkbp:target |
gptkb:plasminogen
|
| gptkbp:UNII |
Q1J8A4N6F2
|
| gptkbp:usedFor |
gptkb:acute_myocardial_infarction
|
| gptkbp:bfsParent |
gptkb:tissue_plasminogen_activator
gptkb:streptokinase |
| gptkbp:bfsLayer |
7
|